Thermo Fisher Scientific (TMO) Q4 Earnings and Revenues Top Estimates

Company Performance - Thermo Fisher Scientific reported quarterly earnings of $6.10 per share, exceeding the Zacks Consensus Estimate of $5.93 per share, and up from $5.67 per share a year ago [1] - The company achieved revenues of $11.4 billion for the quarter ended December 2024, surpassing the Zacks Consensus Estimate by 1.31%, compared to $10.89 billion in the same quarter last year [3] - Over the last four quarters, Thermo Fisher has consistently surpassed consensus EPS estimates four times and revenue estimates three times [2][3] Market Performance - Thermo Fisher shares have increased approximately 9.2% since the beginning of the year, outperforming the S&P 500's gain of 2.7% [4] - The current consensus EPS estimate for the upcoming quarter is $5.33 on revenues of $10.7 billion, and for the current fiscal year, it is $23.11 on revenues of $44.38 billion [8] Industry Outlook - The Medical - Instruments industry, to which Thermo Fisher belongs, is currently ranked in the top 31% of over 250 Zacks industries, indicating a favorable outlook [9] - The performance of Thermo Fisher's stock may be influenced by the overall industry outlook, as research shows that the top 50% of Zacks-ranked industries outperform the bottom 50% by more than 2 to 1 [9]